Quilizumab (Anti-Human IGHE Recombinant Antibody) is a humanized IgG1kappa monoclonal antibody targeting immunoglobulin epsilon (also konwn as: IGHE, IgE). Quilizumab targets the M1-prime fragment of membrane-expressed IGHE/IgE, leading to IGHE/IgE switching and memory B cell depletion. Quilizumab has potential in asthma research[1].
Molecular Weight:
(146.5 kDa)
Purity:
99.83
CAS Number:
[1228538-47-3]
Target:
Apoptosis
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
